In breast cancers, RECQ4 suppression not only impairs DNA synthesis but also increases cellular sensitivity to chemotherapeutic drugs possibly through reduced efficiency in DNA damage response (Arora et al., 2016). The gene discussed is RECQL4; the disease is breast cancer.